|
STX17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.72209999999807E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.4904999999984E-05 |
| Normal-vs-Stage2 |
2.401200E-01 |
| Normal-vs-Stage3 |
4.841400E-03 |
| Normal-vs-Stage4 |
2.526000E-01 |
| Stage1-vs-Stage2 |
4.032000E-01 |
| Stage1-vs-Stage3 |
8.108800E-01 |
| Stage1-vs-Stage4 |
8.171800E-01 |
| Stage2-vs-Stage3 |
4.114000E-01 |
| Stage2-vs-Stage4 |
7.786400E-01 |
| Stage3-vs-Stage4 |
7.371200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39119999999593E-05 |
| Normal-vs-AfricanAmerican |
7.297600E-02 |
| Normal-vs-Asian |
2.522200E-03 |
| Caucasian-vs-AfricanAmerican |
1.503620E-01 |
| Caucasian-vs-Asian |
5.824200E-01 |
| AfricanAmerican-vs-Asian |
3.172600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65273999999105E-05 |
| Normal-vs-Female |
1.201440E-01 |
| Male-vs-Female |
3.630300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.3673999999958E-05 |
| Normal-vs-Extreme_Weight |
2.99650000001872E-06 |
| Normal-vs-Obese |
9.728500E-02 |
| Normal-vs-Extreme_Obese |
9.712400E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.508800E-01 |
| Normal_Weight-vs-Obese |
3.330400E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.224200E-01 |
| Extreme_Weight-vs-Obese |
2.086100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.971800E-01 |
| Obese-vs-Extreme_Obese |
3.775000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.533600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.532300E-02 |
| Normal-vs-Age(61-80Yrs) |
7.62550000033002E-07 |
| Normal-vs-Age(81-100Yrs) |
1.84132999999642E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.523000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.455380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.885900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.200800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.868200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.091000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.335880E-03 |
| Normal-VS-Type2 PRCC |
3.47749999907165E-08 |
| Normal-VS-KIRP CIMP |
5.525400E-01 |
| Normal-VS-Unclassified PRCC |
2.862600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.938700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.804500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.531200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.831100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.271900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.961200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.09699999995794E-07 |
| Normal-vs-N1 |
7.724000E-01 |
| Normal-vs-N2 |
1.920610E-01 |
| N0-vs-N1 |
1.853770E-02 |
| N0-vs-N2 |
8.219800E-01 |
| N1-vs-N2 |
2.408400E-01 |
|
|
